Cyclosporine A plus low‐dose steroid treatment in COVID‐19 improves clinical outcomes in patients with moderate to severe disease: A pilot study
Gálvez‐Romero, J. L., Palmeros‐Rojas, O., Real‐Ramírez, F. A., Sánchez‐Romero, S., Tome‐Maxil, R., Ramírez‐Sandoval, M. P., Olivos‐Rodríguez, R., Flores‐Encarnación, S. E., Cabrera‐Estrada, A. A., Ávila‐Morales, J., Cortés‐Sánchez, V., Sarmiento‐Padilla, G., Tezmol‐Ramírez, S. E., Aparicio‐Hernández, D., Urbina‐Sánchez, M. I., Gómez‐Pluma, M. Á., Cisneros‐Méndez, S., Rodríguez‐Rivas, D. I., Reyes‐Inurrigarro, S., Cortés‐Díaz, G., Cruz‐Delgado, C., Navarro‐González, J., Deveaux‐Homs, J., Pedraza‐Sánchez, S.
Published in Journal of Internal Medicine (01.06.2021)
Published in Journal of Internal Medicine (01.06.2021)
Get full text
Journal Article
Web Resource